bis-q has been researched along with neostigmine in 1 studies
*Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. [MeSH]
*Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. [MeSH]
| Studies (bis-q) | Trials (bis-q) | Recent Studies (post-2010) (bis-q) | Studies (neostigmine) | Trials (neostigmine) | Recent Studies (post-2010) (neostigmine) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 5,020 | 454 | 637 |
| Protein | Taxonomy | bis-q (IC50) | neostigmine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.54 | |
| Cholinesterase | Homo sapiens (human) | 0.45 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.1 | |
| Cholinesterase | Equus caballus (horse) | 2.93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleveland, WL; Erlanger, BF; Hill, BL; Ku, HH; Penn, AS; Sarangarajan, R; Wassermann, NH | 1 |
1 other study(ies) available for bis-q and neostigmine
| Article | Year |
|---|---|
Autoantibodies to receptors by an autoantiidiotypic route.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Autoantibodies; Female; Humans; Immunoglobulin Idiotypes; Male; Mice; Mice, Inbred BALB C; Molecular Conformation; Myasthenia Gravis; Neostigmine; Quaternary Ammonium Compounds; Receptors, Nicotinic; Sex Factors | 1987 |